Home · For Physicians · Pain Management
Pain management
ENFD testing for pain management practices
When nerve conduction studies and EMG, which only assess large fibers, come back normal in a patient with burning, tingling, or numbness, ENFD is often the test that finally confirms small fiber neuropathy (SFN) and gives you an objective, reportable diagnosis to act on.
Small fiber neuropathy
A cause of burning pain that large-fiber studies can miss.
Small fiber neuropathy is a disorder of the peripheral nerves that affect small somatic fibers, autonomic fibers, or both, resulting in sensory changes and/or autonomic dysfunction when both types of fibers are involved.
Symptoms of SFN include pain, burning, tingling and numbness. These symptoms often start in the feet and progress up the rest of the body. Symptoms are often worse at night and affect sleep.
EMG/NCS only evaluate large myelinated fibers, so patients with painful small fiber neuropathy routinely test “normal” on those studies alone.

The test
What ENFD measures.
ENFD (also called intraepidermal nerve fiber density, or IENFD) testing uses a minimally invasive 3-mm skin punch biopsy — performed at CLIA-certified laboratories — to directly visualize and quantify small sensory nerve fibers in the epidermis.
The European Federation of Neurological Societies and the Peripheral Nerve Society guideline (2010) gives distal leg skin biopsy with intraepidermal nerve fiber density quantification its highest recommendation level (Level A) for diagnosing small fiber neuropathy.
“Distal leg skin biopsy with quantification of the linear density of intraepidermal nerve fibers (IENF), using generally agreed upon counting rules, is a reliable and efficient technique to assess the diagnosis of SFN (Recommendation Level A).”
After the report
Confirming the diagnosis.
Confirming the diagnosis of SFN will allow the provider to evaluate possible underlying etiologies efficiently, and aggressively manage the symptoms.
Aggressive cause-specific treatment, lifestyle modifications, and pain control are key elements of managing SFN.
A normal skin biopsy result does not, by itself, rule out small fiber neuropathy. Biopsy findings should be interpreted in the context of the patient’s full clinical presentation.
Practice support
Training, billing, and reports.
- 01
Staff training
The laboratory offers in-office staff training for the ENFD procedure.
- 02
Billing
The laboratory offers direct billing to patient insurance plans. Coverage varies by insurance plan.
- 03
Reports
Reports are typically returned within 10–15 business days.